Green & Grow Inc's largest independent field trial program currently underway

  • GGI has commissioned over 100 independent field trials of Agriplier® for the 2015 season across multiple crops, geographies and seed treatment base packages
  • Recent field trial visits by GGI’s agronomists have confirmed consistent early vigor benefits of Agriplier® Seed Treatment as observed in our 2013 and 2014 trials

Austin, Texas. August 2015: At the mid-point of our 2015 field trial program, Green & Grow Inc. (GGI) is pleased to be able to share some additional details regarding the scope of our independent trial program this year and its progress to date.

In total GGI has commissioned over 100 independent field trials of Agriplier® for 2015. Our trial program focuses on Corn and Soybean Seed Treatment, combining Agriplier® with multiple leading base seed treatment packages in use today and evaluating its performance across a range of geographies and field stress conditions. Additional trials have been commissioned in Canola, Cotton and Wheat as well as selected specialty crops as both a seed treatment and soil amendment.

We look forward to sharing additional data with our industry partners as it becomes available.

American Seed Trade Association

Green & Grow Inc. (GGI) is pleased to announce that its senior leadership team will again be attending the ASTA Corn, Soybean and Sorghum Conference in Chicago.

GGI will be presenting a preview of our latest 2016 independently designed and run field trials utilizing the Agriplier® Technology as a Seed Treatment in Corn, Soybeans, Cotton, Wheat and Canola. These new results will be added to our existing trial data demonstrating the benefits of Agriplier® either as a seed treatment or soil application across multiple crop types.


Green & Grow Inc. (GGI) is pleased to announce that it has obtained its first registered product in Brazil. This marks a milestone in GGI’s efforts to evaluate potential partners in South America. Brazil continues to be a major player in crops where GGI products have performed well.

GGI continues to evaluate other South American markets and pursue registration in those countries.